Pharmacists in Bernalillo, NM Accepting Medicare

7 Pharmacists found. Showing 1 - 7

Bryanna M Vaio Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 460 Nm Hwy 528, Bernalillo, NM 87004 Phone: 505-771-4877

Dr. Erica Butler, PHARM.D, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 460 Highway 528, Bernalillo, NM 87004 Phone: 505-771-4877    Fax: 505-771-4878

Dr. Leo Clifford Vanderpool, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 407 W Hwy 550, Bernalillo, NM 87004 Phone: 505-867-2336    Fax: 505-867-0911

Mr. Felipe Martinez Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Hwy 550, Bernalillo, NM 87004 Phone: 505-867-6071

Vera Oaxaca, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Highway 550, Bernalillo, NM 87004 Phone: 505-867-6071

Deborah Karen Hairgrove, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Hwy 550, Bernalillo, NM 87004 Phone: 505-867-6071    Fax: 505-867-3530

Vineeta Kannan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 203 Sandia Day School Rd., Bernalillo, NM 87004 Phone: 781-985-2132

News Archive

Breakthrough discovery could help young girls suffering from rare form of epilepsy

An international team, led by a University of Adelaide genetics expert, has made a breakthrough discovery which is expected to help thousands of young girls worldwide who are suffering from a rare yet debilitating form of epilepsy.

Idiopathic pulmonary fibrosis (IPF) and herpesvirus saimiri: an interview with Elazar Rabbani, Chief Executive Officer of Enzo

Pulmonary fibrosis is a condition where fibrotic or scarred tissue progressively develops in the lungs. In some cases the particular cause is known but in others it remains unknown and is given the term "idiopathic".

FDA approves first drug for treatment of postpartum depression in adult women

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous use for the treatment of postpartum depression in adult women. This is the first drug approved by the FDA specifically for PPD.

Rhetoric heats up between insurers and lawmakers

Politico: "Sen. Jay Rockefeller (D-W. Va.) is scolding the nations' health insurance companies for 'gaming' the new health care law and is pushing the administration and states to impose stringent controls under the law on industry expenditures for non-medical purposes. Saying the industry had turned its focus from opposing the law to influencing its implementation, Rockefeller said he was 'extremely concerned that the health insurance industry is mounting an all-out effort to weaken' the law.

FDA issues warning letter to Medtronic

Medtronic today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the inspection of the Company's Mounds View, Minn. (Cardiac Rhythm Disease Management) facility completed in August 2009.

Read more Medical News

› Verified 7 days ago